Results 141 to 150 of about 100,295 (288)
Abstract Background Event‐free survival (EFS) and complete response rate (CRR) are recommended as primary endpoints in bladder cancer trials to enable timely assessment of therapeutic benefit. However, their surrogacy relationship with overall survival (OS) in high‐risk non–muscle‐invasive bladder cancer (HR NMIBC) remains unclear.
Rituparna Bhattacharya +8 more
wiley +1 more source
Role of mitomycin in upper digestive tract stricture [PDF]
M. Boyd Gillespie +4 more
openalex +1 more source
Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus [PDF]
Cardenas, Michael L +7 more
core +2 more sources
Hydrogels for Cancer Immunotherapy: Strategies From Construction to Application
Hydrogels offer an innovative platform for cancer immunotherapy. Through tailorable crosslinking strategies, they form customizable drug delivery platforms that address diverse therapeutic requirements by loading specific immunotherapeutic agents. These systems demonstrate significant clinical potential for precise tumor immunotherapy.
Xiaohua Chen +8 more
wiley +1 more source
Risk factors for choroidal detachment after trabeculectomy with mitomycin C
Masaru Inatani +5 more
openalex +2 more sources
Evaluation of Off‐Label Postoperative Inhaled Steroid Use in Tracheal and Cricotracheal Resection
Abstract Objective Tracheal resection (TR) and cricotracheal resection (CTR) are associated with anastomotic complications. Off‐label use of inhaled corticosteroids has gained popularity for reducing tracheal granulation tissue, though adoption remains limited due to unclear safety and efficacy.
Jason Shin Chwa +3 more
wiley +1 more source
Yi-Ping Fang,1,2 Pei-Yu Hu,1 Yaw-Bin Huang1,3 1School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, 2Department of Medical Research, Kaohsiung Medical University Hospital, 3Center for Stem Cell Research, Kaohsiung Medical University ...
Fang YP, Hu PY, Huang YB
doaj
Dose‐dependent effect of mitomycin C on human vocal fold fibroblasts
Nicole Y. K. Li‐Jessen +3 more
openalex +1 more source
Exploring Pembrolizumab‐Induced IM3OS in a Patient With Bladder Cancer
ABSTRACT Pembrolizumab, an immune checkpoint inhibitor (ICI), has transformed cancer treatment across various malignancies, including metastatic urothelial cancer. As the use of pembrolizumab becomes increasingly widespread, understanding its potential adverse effects is essential.
Ching‐Cheng Chan +3 more
wiley +1 more source
Nephrotoxic synergism of cisplatin and mitomycin-C for hyperthermic intraperitoneal chemotherapy and cytoreductive surgery [PDF]
Ravish Kapoor +2 more
openalex +1 more source

